GFAP and pantothenate kinase-associated neurodegeneration: Interestingly, although GFAP concentrations were not elevated in the PKAN group, but they did correlate with NfL and Tau levels, as well as evaluations of dystonia and other neurological signs, including speech, spasticity, and chorea, suggesting it could be a biomarker of disease severity.